PTC Therapeutics, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
A Peek Into Latest 13-F Filing: Top Hedge Fund Stocks
Article By: Sweta Killa
Friday, May 18, 2018 9:08 PM EDT
Investors are mulling over the top bets of big investors like Bill Ackman, George Soros, Carl Icahn, David Tepper, Larry Robbins, Leon Cooperman, Daniel Loeb, David Einhorn and Stanley Druckenmiller, following the first-quarter release of 13F Forms.
In this article: EA, AAPL, ADBE, AMZN, MSFT, NFLX, FB, GOOGL, TWX, UNH, ANTM, CVS, ESRX, GRBK, TUSK, GHDX, ZGNX, RTRX, PCRX, PTCT, CORI, SBBP
Read
3 Biotech And Pharma Stocks With Key FDA Catalysts This October
Article By: Arpita Dutt
Monday, October 2, 2017 10:16 AM EDT
The FDA, which approved 22 novel drugs last year, has given its approval to 34 drugs so far in 2017 including three in September.
In this article: FLXN, ALXN, PTCT Also: JNJ, TSRO, ACRX, AERI
Read
XBI Breaks Through On A Strong Week For Biotech
Article By: Rod Raynovich
Friday, September 29, 2017 7:25 PM EDT
The XBI is up 3.17% this week, 46% YTD, compared to only 1.1% WTD for the IBB. The breakthrough gains for the XBI can be attributed to strong performance of top ten holdings that are primarily mid-caps and M&A prospects.
In this article: BMY, ALNY, BMRN, IBB, AMGN, CELG, CLVS, XBI, JUNO, PBYI, SRPT, BLUE, PTCT, ABBV, FMI
Read
PTC Therapeutics Should Be Bought On Today's Sell-Off, Says Citi
Article By: The Fly
Friday, September 29, 2017 8:43 AM EDT
Citi analyst Joel Beatty, while conceding the FDA is unlikely to approve Translarna after yesterday's 10-1 panel vote in favor of needing more data, recommends buying shares of PTC Therapeutics today on the sell-off.
In this article: PTCT Also: RHHBY
Read
Congressman Supporting Approval Of PTC's DMD Treatment, Says Citi
Article By: The Fly
Monday, September 4, 2017 3:34 PM EDT
Citi analyst Joel Beatty found comments online from U.S. Congressman Collin Peterson that voice support for approval of PTC Therapeutics' Duchenne muscular dystrophy treatment ataluren, which is also known as Translarna.
In this article: PTCT
Read

PARTNER HEADLINES

Latest Tweets for $PTCT

No tweets yet!